Debbie is a Venture Partner in our London office and focuses on the discovery and development of novel medicines and therapeutic platforms. Debbie established the European operations of the Legacy SR One Business in 2005 bringing over 17 years of experience from her accomplished career across a number of operational roles in the pharmaceutical industry. Leveraging her experience in clinical development, business development and licensing, Debbie has a track record of identifying, supporting and growing successful biotech companies. She is a respected and high profile member of the venture community in Europe with a wide ranging network to source, evaluate and shape innovative investments for SR One across multiple geographies. Debbie serves as an independent Director on the Board of Cancer Research Horizons, the commercialization arm of Cancer Research UK and is a member of the Advisory Board of the University of Cambridge Maxwell Centre’s “Impulse” program for young entrepreneurs. SR One Companies: Asceneuron, AtoxBio, Bicycle Therapeutics (BCYC), MiroBio, Mission Therapeutics, Pulmocide, VHsquared Education: Debbie received her B.Sc in Pharmacology from the University of Bath, her Ph.D from the University of London and holds an MBA from Henley Management College.

Source: SR One on 04/10/2023